These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9199064)

  • 21. COX2 selective NSAIDs and renal function: gain without pain?
    Breyer MD
    Kidney Int; 1999 Feb; 55(2):738-9. PubMed ID: 9987099
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible inconsistencies in study on cyclooxygenase.
    Kay-Mugford T; Conlon P
    Am J Vet Res; 1999 Mar; 60(3):275-6. PubMed ID: 10188806
    [No Abstract]   [Full Text] [Related]  

  • 23. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles.
    Fenner H
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):28-33. PubMed ID: 9219317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
    Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes.
    Tsubouchi Y; Sano H; Yamada R; Hashiramoto A; Kohno M; Kusaka Y; Kondo M
    Eur J Pharmacol; 2000 May; 395(3):255-63. PubMed ID: 10812057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of PGH synthase isozymes-1 and -2 with nonsteroidal anti-inflammatory drugs.
    Smith WL; Meade EA; Dewitt DL
    Adv Exp Med Biol; 1997; 400A():189-96. PubMed ID: 9547557
    [No Abstract]   [Full Text] [Related]  

  • 30. [The coxibs].
    Dangoumau J
    Therapie; 2004; 59(2):197. PubMed ID: 15359612
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [COX-2 specific inhibitors are similar--and different].
    Aly A
    Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new NSAID selective COX-2 inhibitor].
    Ledro Cano D; Gómez Rodríguez B; Torres Domínguez Y; Hergueta Delgado P; Herrerías Esteban J; Herrerías Gutiérrez J
    Rev Esp Enferm Dig; 1999 Aug; 91(8):598. PubMed ID: 10491496
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis.
    Sawdy R; Pan H; Sullivan M; Bennett P
    J Obstet Gynaecol; 2003 May; 23(3):239-43. PubMed ID: 12850850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of COX2 inhibitors.
    Flower RJ
    Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COX-2 inhibition: not too hot, not too cold--(perhaps) just right?
    Bakowsky V; Hanly JG
    J Rheumatol; 2000 Dec; 27(12):2734-7. PubMed ID: 11128655
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
    King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P
    Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
    Warner TD; Mitchell JA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
    [No Abstract]   [Full Text] [Related]  

  • 39. Review article: COX-II inhibitors--a new generation of safer NSAIDs?
    Donnelly MT; Hawkey CJ
    Aliment Pharmacol Ther; 1997 Apr; 11(2):227-36. PubMed ID: 9146759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meloxicam inhibits the growth of colorectal cancer cells.
    Goldman AP; Williams CS; Sheng H; Lamps LW; Williams VP; Pairet M; Morrow JD; DuBois RN
    Carcinogenesis; 1998 Dec; 19(12):2195-9. PubMed ID: 9886578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.